Keyword: Takeda

Takeda HQ

10. Novartis/Takeda's Xiidra

Selling Shire’s legacy dry eye drug Xiidra to Novartis is one of several divestitures Takeda inked in 2019 to pare down the huge debt load incurred in its $59 billion takeover of the rare disease giant.